Contact Us
Drug Search Results
More Filters [+]

Tinoridine

Alternative Names: tinoridine
Latest Update: 2022-01-15
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: COX Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Indonesia | Taiwan

Approved Indications: None

Known Adverse Events: None

Company: Takeda
Company Location: TOKYO M0 103-8668
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Tinoridine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Inflammation

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
TI-NF-1001

P4

Completed

Inflammation

2011-10-01

Recent News Events

Date

Type

Title

01/15/2022

PubMed

 Comprehensive degradation profiling and influence of different oxidizing reagents on tinoridine hydrochloride: Structural characterization of its degradation products using HPLC and HRMS.

07/19/2021

PubMed

 Thiophene-Based Compounds with Potential Anti-Inflammatory Activity.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions